LINDSEY ROESSLER: Open Payments
NPI 1851771695 · LEDGEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 48 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $785 · 2025 $796
Food & beverage: $741Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $152 |
| Amgen Inc. | 10 | $150 |
| Novartis Pharmaceuticals Corporation | 12 | $148 |
| ABBVIE INC. | 8 | $135 |
| Ferring Pharmaceuticals Inc. | 3 | $65 |
| UCB, Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| PFIZER INC. | 2 | $36 |
| Avanos Medical | 1 | $15 |
Products named: TREMFYA, COSENTYX, SKYRIZI, EUFLEXXA, RINVOQ, KRYSTEXXA, Bimzelx, ORENCIA.
Industry payments across NJ — which companies pay providers there.
